Twelve Latin American presidents flew to Florida to sign a document pledging military force against drug cartels. The one country most responsible for why those cartels exist and thrive was the host. Nobody at the Shield of the Americas summit mentioned that.
Every Expert in Counter-Narcotics Knows This Won’t Work
There is a concept in drug policy called the Balloon Effect. When you squeeze one part of a balloon — a trafficking route, a cartel’s leadership, a coca-growing region — the pressure doesn’t disappear. It moves. Squeeze hard enough in one spot and it pops up somewhere else, often larger.
Economists and drug policy researchers at RAND Corporation and Brookings have documented this dynamic for decades. Supply-side enforcement has never, in the documented history of U.S. counter-narcotics operations, produced a lasting reduction in the quantity of drugs reaching American consumers. Not in the Andes during the 1990s. Not under Plan Colombia’s $10 billion two-decade investment. Not during the Mérida Initiative. The supply doesn’t shrink. It reorganizes.
The reason is structural. Drug demand in the United States is price inelastic — addicts and heavy users continue consuming at roughly similar quantities even when prices spike significantly. When a trafficking route is interdicted and prices rise briefly, production elsewhere expands to meet the profitable opportunity. The market equilibrates. The cartels adapt. This is not a failure of effort. It is a failure of strategy.
Every counter-narcotics expert who has studied this issue understands it. Trump’s Shield of the Americas addressed none of it.
The United States Is the Largest Drug Consumer on the Planet
The factual baseline, which was not part of the Doral Charter: the United States is the world’s largest consumer of cocaine, fentanyl, and most other controlled substances. Americans’ cocaine use generates annual economic costs exceeding $18 billion, according to industry analysis of National Survey on Drug Use and Health data. Fentanyl has become so prevalent that the CDC reported 79,384 total overdose deaths in the U.S. in 2024 — a decline from previous years, but still representing a catastrophic toll that represents the demand side of the equation.
This demand is why cartels exist. Cartels do not produce drugs for their own consumption. They produce drugs because American consumers pay for them. Remove American demand and the cartel business model collapses. Maintain American demand and destroying one cartel creates a vacancy that competitors will violently fill within months. As NPR reported on Trump’s fentanyl plans in 2024, addiction experts warned that approximately 90% of people convicted of fentanyl smuggling are U.S. citizens, not Mexicans or migrants — meaning the enforcement chain is catching American distributors while the demand continues unchanged.
Trump’s response to this reality: the administration terminated approximately $2 billion in SAMHSA grants targeting addiction and mental health programs in January 2026, reversed the decision less than 24 hours later under bipartisan pressure, then proposed over $1 billion in further SAMHSA cuts in the FY 2026 budget. Programs eliminated in the proposal include overdose prevention education, naloxone distribution, treatment for homeless individuals, and programs for pregnant women in recovery. These are demand-side interventions. They are being cut while the military anti-supply coalition gets signed at a golf resort.
Designating Fentanyl as a WMD Signals the Same Category Error
In December 2025, the Trump administration designated fentanyl as a weapon of mass destruction. Brookings Institution analysts warned this was likely to misfire. The WMD framework treats fentanyl as an external attack — something being done to America by hostile foreign actors — rather than as a product being sold to Americans who want to buy it.
The framing is politically useful and analytically useless. It assigns full moral and causal responsibility to foreign suppliers and removes any domestic responsibility from the demand side of the transaction. It also conveniently justifies military action abroad without requiring any uncomfortable policy discussions at home — about the cost and accessibility of addiction treatment, about the failure of criminalization as a deterrent, about the communities where overdose rates are highest and treatment is scarcest.
The New York Times’ coverage of the Doral summit quoted Trump comparing the cartel coalition to the anti-ISIS campaign: “We must now do the same thing to eradicate the cartels at home.” But ISIS was a territorial government that could be physically destroyed. Drug cartels are market participants. You can kill a cartel’s leadership. You cannot kill the price signal that makes cartel membership economically rational in communities with limited alternatives. Those are different problems that require different tools.
The Historical Record Is Not Ambiguous
The U.S. has tried the military supply-side approach repeatedly. In the 1980s, 80% of U.S. cocaine entered through Miami. Enforcement focused there. By the 2000s, 90% of U.S. cocaine crossed the U.S.-Mexico border, handled by Mexican traffickers who had moved into the space. The cocaine supply to American consumers was uninterrupted. The violence migrated to Mexico, where the drug war death toll has now surpassed 400,000.
Plan Colombia ran from 2000 to roughly 2016, spending over $10 billion. A 2016 peace agreement in Colombia led to farmers returning to coca cultivation almost immediately because no viable economic alternatives existed. UN findings showed no net change in cocaine production across the Plan Colombia period, contradicting U.S. government claims of a 72% reduction. The cocaine kept coming because the Americans kept buying.
The Shield of the Americas coalition includes none of the demand-side components that researchers identify as the interventions with meaningful long-run impact: treatment access, harm reduction, economic alternatives in cartel-recruiting communities. It is entirely supply-side military pressure. The RAND Corporation’s assessment of this approach is three decades old: supply-side enforcement produces minor, short-lived price spikes and no lasting reduction in consumption.
What This Actually Means
The Shield of the Americas summit will produce military operations that will kill cartel members, destroy labs, and interdict shipments. It will be declared a success in press releases. And within two to five years, the underlying drug supply to American consumers will be statistically indistinguishable from what it was before, because the structural driver — American demand — will remain fully intact and unaddressed.
The experts know this. The drug policy researchers know this. The economists who study illicit markets know this. What makes the Shield of the Americas notable isn’t that it’s a new approach. It’s that it repeats the same approach that failed in 1989, 2000, 2009, and every iteration in between — while simultaneously cutting the addiction treatment programs that constitute the only interventions with documented demand-reduction impact. The goal is eradication. The method guarantees continuation.
Sources
The New York Times |
RAND Corporation |
Brookings Institution |
NPR |
Behavioral Health Business |
NACLA |
Partnership to End Addiction
Background
What is SAMHSA? The Substance Abuse and Mental Health Services Administration is the U.S. federal agency within the Department of Health and Human Services that leads public health efforts to advance behavioral health and provides grants to states and organizations for addiction treatment, mental health services, and overdose prevention programs. With a budget of approximately $7.3 billion in 2024, SAMHSA is the primary federal mechanism for funding demand-side drug interventions — the programs that treat addiction rather than interdict supply.
What is the Balloon Effect in drug policy? The Balloon Effect describes how enforcement pressure on drug supply chains simply displaces production and trafficking rather than eliminating it. When one trafficking corridor is closed or one cartel is destroyed, the market demand persists, creating profitable opportunities for competitors to fill the gap. The concept was documented in U.S. policy analysis as early as the 1990s and has been observed consistently across decades of anti-narcotics operations in Latin America.